EmergingResearch compound

Unifiram

Ampakine (DM-232), alkynyl variant of Sunifiram, AMPA-PAM.

Telegram

WHAT IS UNIFIRAM?

Detailed overview

Unifiram (DM-232) is a designed alkynyl analog of Sunifiram (DM-235), with similar sub-mg in vivo activity in rat anti-amnestic models. Interestingly it does NOT directly act as an AMPA-PAM (unlike classical ampakines) – instead it improves glutamatergic signal-processing efficiency, enhancing how memory circuits respond to glutamate. Indirect activation at the NMDA glycine site + acetylcholine release modulation in cerebral cortex. Long-lasting hippocampal LTP elevation. Less activating than Sunifiram, more pro-cognitive profile; data report no adverse effects in studied models. No human data exist.

Mechanism

AMPA-PAM (Sunifiram-like)

Half-life

No human data

Legal status

Investigational, not approved

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • No human safety data, only preclinical (rodent) and anecdotal reports
  • Anxiety, tension and restlessness (highly individual response)
  • Stimulating, energizing effect that can tip into overstimulation at higher doses
  • Possible sleep disruption if taken late in the day (stimulant-like profile)
  • Headache or agitation theoretically arising from glutamatergic (AMPA/NMDA) modulation
  • Unknown long-term safety, unknown tolerance and risk profile

Contraindications · 5

  • Pregnancy and breastfeeding: strictly avoid due to lack of human data
  • Caution with anxiety disorders or panic tendency (the stimulating effect may worsen them)
  • Epilepsy or seizure-threshold disorders: glutamatergic excitation may theoretically raise seizure risk
  • Combined with other stimulants or caffeine, increased agitation and anxiety are possible
  • Experimental, nowhere-approved substance; no established safe dosing or drug-interaction profile

Related Nootropics

Same therapeutic category

Telegram

Have a question about Unifiram?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Telegram
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: June 19, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.